Qingyi Wei, Professor at Duke University School of Medicine and Associate Director of Duke Cancer Institute, Duke University Medical Center, was elected to be the new president of USCACA at the joint meeting of USCACA and ACACR at the 2017 AACR Annual meeting in Washington DC.
Dr. George Wilding, a Board Member of USCACA and the Vice Provost of MD Anderson Cancer Center, led a delegation to attend the 2nd International Conference on Translational Cancer Research held in Tianjin during August 2016. Dr. Wilding and Dr. Ping Wang, the President of Tianjin Medical University Cancer Hospital and Institute, also signed an Agreement to continue the Sister Institute Relationship for 5 additional years after 10 years’ highly successful partnership.
USCACA is an endorser of the World Precision Medicine Summit 2016 to be held in Shanghai during December 3-4. Dr.Wei Zhang will serve as a moderator and panel discussant.USCACA friend, the Director of Wake Forest Cancer Center, Dr. Boris Pasche will deliver a keynote speech on precision oncology initiative at Wake Forest.